Lo Russo and colleagues found that HPD was associated with tumor-associated macrophages with M2-differentiation and myeloperoxidase (MPO)+ myeloid cells, and that PD-1 inhibition induced FcR triggering of M2-macrophages, promoting aggressive protumorigenic behavior [14]. Here, PDCD1 is linked to neoplasm.